(Q44468300)

English

Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection (English)

1 reference

Europe PubMed Central

3 December 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

3 December 2017

author name string

Ho Suk Oh

1

1 reference

Europe PubMed Central

3 December 2017

Gil Hyun Kang

3

1 reference

Europe PubMed Central

3 December 2017

Yong Chel Ahn

4

1 reference

Europe PubMed Central

3 December 2017

Sang Jin Lee

5

1 reference

Europe PubMed Central

3 December 2017

Ji-Hoon Kim

6

1 reference

Europe PubMed Central

3 December 2017

Hyuk Jai Jang

7

1 reference

Europe PubMed Central

3 December 2017

Eun Jung Kim

8

1 reference

Europe PubMed Central

3 December 2017

Kwang Hoon Oh

9

1 reference

Europe PubMed Central

3 December 2017

Heui June Ahn

10

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 August 2013

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

17

1 reference

Europe PubMed Central

3 December 2017

3

1 reference

Europe PubMed Central

3 December 2017

402-411

1 reference

Europe PubMed Central

3 December 2017

describes a project that uses

immunohistochemistry

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1007/s10120-013-0288-0

0 references

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

National cancer incidence for the year 2002 in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Predictors of operative morbidity and mortality in gastric cancer surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Gastrointestinal cancer: recent developments in medical oncology.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Inhaled nitric oxide for adult respiratory distress syndrome after pulmonary resection.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

[Her2 testing in gastric cancer. What is different in comparison to breast cancer?].

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

HER-2 expression in immunohistochemistry has no prognostic significance in gastric cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Patterns of somatic mutation in human cancer genomes

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0288-0

21 January 2018

Extended lymph-node dissection for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended lymphadenectomy in gastric cancer: when, for whom and why

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tailoring treatments for curable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer].

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the optimal extent of lymph node dissection for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/23955257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-013-0288-0

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44468300&oldid=2024940778"